Product
Pro-ocular
3 clinical trials
3 indications
Indication
Dry Eye SyndromeIndication
Ocular Graft-versus-host DiseaseIndication
Chronic Ocular Graft-versus-host DiseaseClinical trial
A Multicenter, Randomized, Double-Masked, Placebo-Controlled Phase II Study to Evaluate the Safety and Efficacy of Pro-ocular™ 0.5% and 1% in Patients With Dry Eye SyndromeStatus: Completed, Estimated PCD: 2022-10-27
Clinical trial
A Phase II/III Trial of Safety and Efficacy of Pro-ocular™ 1% in Daily Scleral Lens Wearing Patients With Ocular Graft-versus-Host DiseaseStatus: Active (not recruiting), Estimated PCD: 2023-08-15
Clinical trial
Treatment Safety and Efficacy Using Pro-ocular™ 1% for Chronic Ocular Graft-versus-host Disease (GvHD) Following Allogeneic Hematopoietic Stem Cell Transplantation.Status: Completed, Estimated PCD: 2021-10-31